Literature DB >> 25147414

Identification of a novel structure in heparin generated by potassium permanganate oxidation.

Daniela Beccati1, Sucharita Roy1, Fei Yu1, Nur Sibel Gunay1, Ishan Capila1, Miroslaw Lech1, Robert J Linhardt2, Ganesh Venkataraman1.   

Abstract

The worldwide heparin contamination crisis in 2008 led health authorities to take fundamental steps to better control heparin manufacture, including implementing appropriate analytical and bio-analytical methods to ensure production and release of high quality heparin sodium product. Consequently, there is an increased interest in the identification and structural elucidation of unusually modified structures that may be present in heparin. Our study focuses on the structural elucidation of species that give rise to a signal observed at 2.10 ppm in the N-acetyl region of the 1H NMR spectrum of some pharmaceutical grade heparin preparations. Structural elucidation experiments were carried out using homonuclear (COSY, TOSCY and NOESY) and heteronuclear (HSQC, HSQC-DEPT, HMQC-COSY, HSQC-TOCSY, and HMBC) 2D NMR spectroscopy on both heparin as well as heparin-like model compounds. Our results identify a novel type of oxidative modification of the heparin chain that results from a specific step in the manufacturing process used to prepare heparin.

Entities:  

Keywords:  1H NMR; HSQC; Heparin; N-Acetylglucosamine; Oxidation; Permanganate; Reducing end

Year:  2010        PMID: 25147414      PMCID: PMC4138061          DOI: 10.1016/j.carbpol.2010.05.038

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  11 in total

Review 1.  Structural characterization of low molecular weight heparins.

Authors:  B Casu; G Torri
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

2.  2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.

Authors:  Robert J Linhardt
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

3.  Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events.

Authors:  Marco Guerrini; Daniela Beccati; Zachary Shriver; Annamaria Naggi; Karthik Viswanathan; Antonella Bisio; Ishan Capila; Jonathan C Lansing; Sara Guglieri; Blair Fraser; Ali Al-Hakim; Nur Sibel Gunay; Zhenqing Zhang; Luke Robinson; Lucinda Buhse; Moheb Nasr; Janet Woodcock; Robert Langer; Ganesh Venkataraman; Robert J Linhardt; Benito Casu; Giangiacomo Torri; Ram Sasisekharan
Journal:  Nat Biotechnol       Date:  2008-04-23       Impact factor: 54.908

Review 4.  Heparinoids: structure, biological activities and therapeutic applications.

Authors:  N S Gunay; R J Linhardt
Journal:  Planta Med       Date:  1999-05       Impact factor: 3.352

5.  'Heparin'--from anticoagulant drug into the new biology.

Authors:  U Lindahl
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

6.  Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid.

Authors:  H Uchiyama; Y Dobashi; K Ohkouchi; K Nagasawa
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

7.  Discovery and characterization of sialic acid O-acetylation in group B Streptococcus.

Authors:  Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

Review 8.  Heparin and heparan sulfate biosynthesis.

Authors:  Kazuyuki Sugahara; Hiroshi Kitagawa
Journal:  IUBMB Life       Date:  2002-10       Impact factor: 3.885

9.  Contaminated heparin associated with adverse clinical events and activation of the contact system.

Authors:  Takashi Kei Kishimoto; Karthik Viswanathan; Tanmoy Ganguly; Subbiah Elankumaran; Sean Smith; Kevin Pelzer; Jonathan C Lansing; Nammalwar Sriranganathan; Ganlin Zhao; Zoya Galcheva-Gargova; Ali Al-Hakim; Gregory Scott Bailey; Blair Fraser; Sucharita Roy; Thomas Rogers-Cotrone; Lucinda Buhse; Mark Whary; James Fox; Moheb Nasr; Gerald J Dal Pan; Zachary Shriver; Robert S Langer; Ganesh Venkataraman; K Frank Austen; Janet Woodcock; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-04-23       Impact factor: 91.245

Review 10.  Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy.

Authors:  Marco Guerrini; Sara Guglieri; Annamaria Naggi; Ram Sasisekharan; Giangiacomo Torri
Journal:  Semin Thromb Hemost       Date:  2007-07       Impact factor: 4.180

View more
  6 in total

Review 1.  Heparin and heparan sulfate: analyzing structure and microheterogeneity.

Authors:  Zachary Shriver; Ishan Capila; Ganesh Venkataraman; Ram Sasisekharan
Journal:  Handb Exp Pharmacol       Date:  2012

2.  Fucosylated chondroitin sulfates from the body wall of the sea cucumber Holothuria forskali: conformation, selectin binding, and biological activity.

Authors:  Charalampos G Panagos; Derek S Thomson; Claire Moss; Adam D Hughes; Maeve S Kelly; Yan Liu; Wengang Chai; Radhakrishnan Venkatasamy; Domenico Spina; Clive P Page; John Hogwood; Robert J Woods; Barbara Mulloy; Charlie D Bavington; Dušan Uhrín
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

Review 3.  From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods.

Authors:  Jan-Ytzen van der Meer; Edwin Kellenbach; Leendert J van den Bos
Journal:  Molecules       Date:  2017-06-21       Impact factor: 4.411

Review 4.  General Considerations for Diversifying Heparin Drug Products by Improving the Current Heparin Manufacturing Process and Reintroducing Bovine Sourced Heparin to the US Market.

Authors:  Ali Al-Hakim
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

5.  Characterization of Danaparoid Complex Extractive Drug by an Orthogonal Analytical Approach.

Authors:  Cristina Gardini; Elena Urso; Marco Guerrini; René van Herpen; Pauline de Wit; Annamaria Naggi
Journal:  Molecules       Date:  2017-07-05       Impact factor: 4.411

6.  SAX-HPLC and HSQC NMR Spectroscopy: Orthogonal Methods for Characterizing Heparin Batches Composition.

Authors:  Franco Spelta; Lino Liverani; Alessandra Peluso; Maria Marinozzi; Elena Urso; Marco Guerrini; Annamaria Naggi
Journal:  Front Med (Lausanne)       Date:  2019-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.